Luxturna, a drug for gene therapy to cure inherent blindness that was recently approved by the FDA, will cost $850,000. Does the prohibitive cost outweigh the advantages of a one-time treatment to cure a hereditary disease?
Gene Therapy To Treat Inherent Blindness Will Cost $850,000: Is This The Future Of Medicine?
Tech Times - 4 Jan 2018 13:13
Luxturna, a drug for gene therapy to cure inherent blindness that was recently approved by the FDA, will cost $850,000. Does the prohibitive cost outweigh the advantages of a one-time treatment to cure a hereditary disease?
Share this Article
Recommended